AHA: Percutaneous Coronary Intervention Significantly Cuts Angina Symptoms

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- Percutaneous coronary intervention (PCI) improves symptoms versus placebo among patients with stable angina and taking no chest pain medication, according to a study published online Nov. 11 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.

Christopher A. Rajkumar, M.B.B.S., from Imperial College London, and colleagues compared PCI versus placebo for angina relief in patients who were not receiving antianginal medication. The analysis included 301 patients randomly assigned to PCI or placebo with 12 weeks of follow-up.

The researchers found that at follow-up, the mean angina symptom score was 2.9 in the PCI group versus 5.6 in the placebo group (odds ratio, 2.21). Unacceptable angina occurred in one patient in the placebo group, resulting in unblinding. Four patients in the PCI group experienced acute coronary syndromes versus six patients in the placebo group.

"Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," coauthor Rasha Al-Lamee, M.B.B.S., Ph.D., also from Imperial College London, said in a statement. "The key finding of this trial is that it is the first therapy initiated that seems to have the maximum effect. Although PCI is neither risk-free nor cost-free, its use as an upfront procedure can now be considered evidence-based."

The study was funded in part by Philips.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-18 00:48

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords